Can PV Cause Brain Fog, Headaches, and Blurry Vision?
At a Glance
Polycythemia vera can contribute to brain fog, headaches, and blurry vision when thickened blood affects small blood vessels, but other causes are possible. Keeping the red blood cell level controlled may help, while sudden neurological or visual changes require emergency care.
In this answer
4 sections
If you are living with Polycythemia Vera (PV), you may wonder if the disease is causing your headaches, blurry vision, or brain fog. While PV can certainly contribute to these cognitive and neurological issues—which are well-recognized symptoms of the condition—it is important not to assume PV is the sole cause without a medical evaluation [1]. These symptoms can also stem from migraines, blood pressure changes, medication side effects, or unrelated eye and neurological conditions.
However, when these symptoms are related to PV, they often stem from how the disease affects your blood flow and microvascular system (your smallest blood vessels) [2] [3].
How Thickened Blood Affects Your Body
PV causes your body to overproduce red blood cells, which makes your blood abnormally thick—a state known as hyperviscosity. This thickness changes how blood moves through the body [2].
When your hematocrit—the percentage of your blood made up of red blood cells—rises above normal levels, blood flow can slow down. This slower blood flow can impair how well the microcirculation in your brain and eyes functions [2] [3]. While the exact mechanism is complex and multifactorial, including inflammation and platelet activity, impaired blood flow is a key contributor to several symptoms:
- Brain fog and cognitive issues: Slower circulation in the brain can contribute to difficulty concentrating, memory issues, or mental cloudiness [1] [4].
- Headaches and dizziness: Increased blood volume and viscosity can create changes in flow within the brain, which may trigger headaches or dizziness [5].
- Blurry vision: The delicate blood vessels in your retinas are highly sensitive to reduced blood flow. Sluggish circulation here can cause visual disturbances or temporary blurry vision [6] [7].
Managing Symptoms Through Treatment
Medical guidelines strongly recommend keeping your hematocrit below 45%. This target is primarily set to lower your risk of serious blood clots (thrombosis), but bringing your blood counts into a safer range may also help improve blood flow and reduce some symptoms [8] [9]. However, symptom response varies from person to person, and reaching this target does not guarantee your brain fog or headaches will completely resolve [10] [11].
Your hematologist may use different approaches to manage your condition:
- Phlebotomy: A planned blood draw that removes a measured amount of blood to physically lower your red blood cell count and thin your blood [6].
- Cytoreductive therapies: Medications (such as hydroxyurea or ruxolitinib) that slow down the bone marrow’s production of blood cells. These are tailored to the individual patient, and clinical studies show they can reduce overall symptom burden for some people [12] [13].
The “Iron Deficiency” Connection
If your hematocrit is controlled but your brain fog or fatigue persists, iron deficiency may be a factor. Iron deficiency is a common consequence of repeated phlebotomies, because the procedure removes iron along with red blood cells [14].
Low iron levels (measured by ferritin, a marker of stored iron) can directly cause fatigue, poor concentration, and brain fog—even if you are not technically anemic [14] [15].
Important Safety Note: Never start iron supplements on your own. In PV, iron replacement can dangerously accelerate red blood cell production. Always discuss your ferritin levels and persistent cognitive symptoms with your hematologist, who can safely interpret these studies and determine the best course of action [13].
When to Seek Emergency Medical Care
While persistent cognitive and visual symptoms can be frustrating, any new, sudden, unusual, or worsening neurological change requires urgent medical assessment. Even if a symptom like temporary vision loss or numbness resolves after a few minutes, it could be a transient ischemic attack (TIA) (a temporary blockage of blood flow) or a retinal blood clot, both of which require same-day emergency evaluation [2] [16].
Call your local emergency services and do not drive yourself if you experience:
- Sudden vision loss in one or both eyes, or a “curtain” coming down over your field of vision [6]
- Sudden weakness, numbness, or paralysis on one side of your face, arm, or leg [16]
- Sudden difficulty speaking, slurred speech, or trouble understanding others [16]
- A sudden, explosive headache unlike any you have had before [17]
- Chest pain, shortness of breath, coughing up blood, or a painful swollen leg (signs of major blood clots) [9]
Common questions in this guide
Can polycythemia vera cause brain fog, headaches, and blurry vision?
Will lowering my hematocrit improve PV-related brain fog or headaches?
Can iron deficiency cause brain fog in someone with polycythemia vera?
What treatments are used when PV symptoms do not improve?
When are headache or vision changes an emergency with PV?
What should I ask my doctor about ongoing brain fog or fatigue with PV?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my hematocrit consistently staying below the recommended 45% target, and how are my platelet and white blood cell counts looking?
- 2.Could my brain fog and fatigue be related to low iron (ferritin) levels, medication side effects, or sleep issues?
- 3.What are the individualized risks and benefits of starting or adjusting cytoreductive therapy if my cognitive and visual symptoms aren't improving?
- 4.What is our plan for monitoring my iron levels, and what should I do if my symptoms persist?
- 5.When should I contact your office versus going to the emergency room for a new headache or visual change?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
[Diagnosis and treatment of polycythaemia vera: state of the art].
Marton I, Simon Z, Borbényi Z
Orvosi hetilap 2016; (157(44)):1743-1751 doi:10.1556/650.2016.30583.
PMID: 27796129 - 2
Recurrent Stroke with Rapid Development of Intracranial Stenoses in Polycythemia Vera.
Crespo AM, Abraira L, Guanyabens N, et al.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016; (25(4)):e41-3.
PMID: 26825349 - 3
Polycythemia vera as a rare cause of hypertension in a young man.
Vetluzhskaya M, Abramova A, Oganesyan K, Podzolkov V
BMJ case reports 2021; (14(6)) doi:10.1136/bcr-2021-242008.
PMID: 34162611 - 4
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.
Mesa R, Boccia RV, Grunwald MR, et al.
Clinical lymphoma, myeloma & leukemia 2018; (18(9)):590-596 doi:10.1016/j.clml.2018.05.020.
PMID: 30122202 - 5
Polycythemia vera disease profile in an African population-experience from a tertiary facility in Ghana.
Gyabaah S, Ahmed EA, Adu-Gyamfi AA, et al.
SAGE open medicine 2023; (11()):20503121231187747 doi:10.1177/20503121231187747.
PMID: 37529706 - 6
Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report.
Regensburger J, Rauchegger T, Loacker L, et al.
BMC ophthalmology 2022; (22(1)):221 doi:10.1186/s12886-022-02423-w.
PMID: 35570268 - 7
Diagnosis and Treatment of Polycythemia Vera: A Review.
Tremblay D, Kremyanskaya M, Mascarenhas J, Hoffman R
JAMA 2025; (333(2)):153-160 doi:10.1001/jama.2024.20377.
PMID: 39556352 - 8
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
Gerds AT, Mesa R, Burke JM, et al.
Blood 2024; (143(16)):1646-1655 doi:10.1182/blood.2023020232.
PMID: 38142448 - 9
Thromboembolic events in polycythemia vera.
Griesshammer M, Kiladjian JJ, Besses C
Annals of hematology 2019; (98(5)):1071-1082 doi:10.1007/s00277-019-03625-x.
PMID: 30848334 - 10
The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.
Scherber RM, Geyer HL, Dueck AC, et al.
Leukemia & lymphoma 2017; (58(6)):1481-1487 doi:10.1080/10428194.2016.1246733.
PMID: 27830999 - 11
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study.
Grunwald MR, Burke JM, Kuter DJ, et al.
Clinical lymphoma, myeloma & leukemia 2019; (19(9)):579-584.e1 doi:10.1016/j.clml.2019.06.001.
PMID: 31303457 - 12
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
Vannucchi AM, Kiladjian JJ, Griesshammer M, et al.
The New England journal of medicine 2015; (372(5)):426-35 doi:10.1056/NEJMoa1409002.
PMID: 25629741 - 13
Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy.
Verstovsek S, Harrison CN, Kiladjian JJ, et al.
Leukemia research 2017; (56()):52-59 doi:10.1016/j.leukres.2017.01.032.
PMID: 28193568 - 14
Dysregulated iron metabolism in polycythemia vera: etiology and consequences.
Ginzburg YZ, Feola M, Zimran E, et al.
Leukemia 2018; (32(10)):2105-2116 doi:10.1038/s41375-018-0207-9.
PMID: 30042411 - 15
Iron deficiency and phlebotomy in patients with polycythemia vera.
Edahiro Y, Komatsu N
International journal of hematology 2025; (121(1)):39-44 doi:10.1007/s12185-024-03868-z.
PMID: 39528901 - 16
Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm.
Ong E, Barraco F, Nighoghossian N, et al.
Revue neurologique 2016; (172(11)):703-708 doi:10.1016/j.neurol.2016.09.010.
PMID: 28241944 - 17
Concomitant Cerebral Venous Thrombosis and Intracranial Hemorrhages in Presentation of a Patient with Secondary Polycythemia: A Case Report.
Fahrurriza H, Gofir A, Setyawan TR, et al.
The American journal of case reports 2023; (24()):e941507 doi:10.12659/AJCR.941507.
PMID: 37838828
This page is for informational purposes only and does not constitute medical advice. It explains how polycythemia vera may contribute to cognitive or visual symptoms; your hematologist should evaluate persistent symptoms, and sudden neurological changes require emergency care.
Get notified when new evidence is published on Polycythemia vera.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.